Jiang Z Y, Liu W F, Zhang X M, et al.Anti-HBV active constituents from Piper longum [J].Bioorg Med Chem Lett, 2013, 23(7):2123.
[3]
Lee C S, Han E S, Kim Y K.Piperine inhibition of 1-methyl-4-phenylpyridinium-induced mitochondrial dysfunction and cell death in PC12 cells[J].Eur J Pharmacol,2006,537(1/3):37.
[4]
Shrivastava P, Vaibhav K, Tabassum R, et al.Anti-apoptotic and anti-inflammatory effect of piperine on 6-OHDA induced Parkinson\'s rat model [J].J Nutr Biochem, 2013, 24(4):680.
Liu J H, Bi Y, Luo R, et al.Simultaneous UFLC-ESI-MS/MS determination of piperine and piperlonguminine in rat plasma after oral administration of alkaloids from Piper longum L.: application to pharmacokinetic studies in rats [J].J Chromatogr B, 2011, 879(27):2885.
[8]
Liu H L, Luo R, Chen X, et al.Tissue distribution profiles of three antiparkinsonian alkaloids from Piper longum L.in rats determined by liquid chromatography-tandem mass spectrometry [J].J Chromatogr B, 2013, 928:78.
[9]
Paxinos G, Watson C.The rat brain in stererotaxic coordinates[M].3th ed.San Diego: Academic Press, 1997:86.
[10]
Liu D Z, Zhu J, Jin D Z, et al.Behavioral recovery following sub-chronic paeoniflorin administration in the striatal 6-OHDA lesion rodent model of Parkinson\'s disease [J].J Ethnopharmacol, 2007, 112(2):327.
[11]
Schapira A H, Jenner P.Etiology and pathogenesis of Parkinson\'s disease [J].Mov Disord, 2011, 26 (6):1049.
Pathak N, Khandelwal S.Modulation of cadmium induced alterations in murine thymocytes by piperine: oxidative stress, apoptosis, phenotyping and blastogenesis[J].Biochem Pharmacol, 2006,72 (4):486.
Chan H H, Kumar S, Zhuo L.Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson\'s disease induced by 6-OHDA [J].Eur J Pharmacol, 2013, 715(1/3):405.
[17]
Veeru P, Kishor M P, Meenakshi M.Screening of medicinal plant extracts for antioxidant activity[J].J Med Plants Res, 2009, 3(8):608.
[18]
Hudson J L, van Horne C G, Stromberg I, et al.Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats[J].Brain Res, 1993, 626(1/2):167.
[19]
Iancu R, Mohapel P, Brundin P, et al.Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson\'s disease in mice [J].Behav Brain Res, 2005,162(1):1.
[20]
Kumar H, Lim H W, More S V, et al.The role of free radicals in the aging brain and Parkinson\'s disease: convergence and parallelism [J].Int J Mol Sci, 2012, 13(8):10478.
Khan M M, Raza S S, Javed H, et al.Rutin protects dopaminergic neurons from oxidative stress in an animal model of Parkinson\'s disease [J].Neurotox Res, 2012, 22(1):1.
[23]
Yu Y P, Ju W P, Li Z G, et al.Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat [J].Brain Res, 2010, 1336:58.
[24]
Gomes M Z, Raisman-Vozari R, Del Bel E A.A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway [J].Brain Res, 2008, 1203:160.
